Loading...

Home
ETF
TVRD

TVRD

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TVRD News

Tvardi to Present TTI-101 Clinical Data at 44th J.P. Morgan Healthcare Conference

Jan 08 2026Globenewswire

Tvardi Therapeutics Shares Plunge 80% Following Disappointing Phase 2 Trial Data

Dec 24 2025Globenewswire

Faruqi & Faruqi Investigates Potential Claims Against Tvardi Therapeutics (NASDAQ:TVRD)

Dec 23 2025PRnewswire

Tvardi Therapeutics Shares Plunge 80% Following Phase 2 Trial Disappointment

Dec 21 2025Businesswire

Tvardi Therapeutics Shares Plunge 80% After Phase 2 Trial Disappointment

Dec 20 2025Globenewswire

Faruqi & Faruqi Investigates Claims for Investors in Tvardi Therapeutics Following Significant Losses

Dec 17 2025PRnewswire

Faruqi & Faruqi Investigates Potential Claims Against Tvardi Therapeutics (NASDAQ:TVRD)

Dec 11 2025PRnewswire

Faruqi & Faruqi Investigates Investor Losses in Tvardi Therapeutics

Dec 04 2025PRnewswire

Faruqi & Faruqi Investigates Investor Losses in Tvardi Therapeutics

Nov 30 2025PRnewswire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Looks into Claims for Tvardi Therapeutics Investors

Nov 29 2025Globenewswire

Investor Alert: Faruqi & Faruqi, LLP Probes Allegations for Tvardi Therapeutics Investors

Nov 20 2025Globenewswire

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi

Nov 14 2025PRnewswire

TVRD Investors Can Participate in Fraud Investigation of Tvardi Therapeutics, Inc. Led by the Schall Law Firm

Nov 12 2025Globenewswire

TVRD SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Looks into Claims for Tvardi Therapeutics Investors

Nov 09 2025Globenewswire

Investor Alert: Faruqi & Faruqi, LLP Probes Allegations for Tvardi Therapeutics Investors

Nov 04 2025Globenewswire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Nov 03 2025PRnewswire